Tributary Capital Management’s Cardinal Financial Corp CFNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-503,414
Closed -$15.1M 204
2017
Q1
$15.1M Buy
503,414
+97,920
+24% +$3.02M 1.47% 22
2016
Q4
$13.3M Buy
405,494
+27,898
+7% +$825K 1.56% 15
2016
Q3
$9.85M Sell
377,596
-165,082
-30% -$4.15M 1.28% 24
2016
Q2
$11.9M Buy
542,678
+55,177
+11% +$1.19M 1.74% 2
2016
Q1
$9.92M Buy
487,501
+42,096
+9% +$824K 1.57% 4
2015
Q4
$10.1M Sell
445,405
-7,272
-2% -$171K 1.68% 1
2015
Q3
$10.4M Buy
452,677
+3,937
+0.9% +$89.6K 1.74% 1
2015
Q2
$9.78M Buy
448,740
+10,983
+3% +$229K 1.52% 2
2015
Q1
$8.75M Buy
437,757
+28,777
+7% +$551K 1.37% 5
2014
Q4
$8.11M Buy
408,980
+106,885
+35% +$1.97M 1.38% 5
2014
Q3
$5.16M Buy
302,095
+16,970
+6% +$304K 1.08% 11
2014
Q2
$5.26M Buy
285,125
+3,060
+1% +$53.8K 1.05% 10
2014
Q1
$5.03M Buy
282,065
+142,264
+102% +$2.51M 1.06% 9
2013
Q4
$2.52M Buy
+139,801
New +$2.38M 0.5% 106

Other funds holding CFNL

Tributary Capital Management's CFNL Position: Q2 2017 in Review

Tributary Capital Management sold out of Cardinal Financial Corp (CFNL) in Q2 2017, closing a stake of 503,414 shares — an estimated $15.1M sold.

Tributary Capital Management first reported a position in CFNL in Q4 2013 and held it in 14 quarters. The position peaked at $15.1M in Q1 2017. 1 fund tracked by Wall St. Rank holds CFNL as of Q2 2017.

  • Tributary Capital Management reported no remaining Cardinal Financial Corp position as of Q2 2017 after selling out during the quarter.
  • Tributary Capital Management sold 503,414 Cardinal Financial Corp shares in Q2 2017, an estimated $15.1M.
  • Tributary Capital Management first reported a position in Cardinal Financial Corp in Q4 2013 and held it in 14 quarters.
  • Tributary Capital Management's Cardinal Financial Corp position peaked at $15.1M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Cardinal Financial Corp as of Q2 2017.

Based on Tributary Capital Management's 13F filing for Q2 2017, filed 24 Jul 2017.